E-DRUG: Managing conflicts of interest in national pharmaceutical systems: online information session 4 October 14:00 CET
-------------------------------------------------------------------------
WHO-in collaboration with the United States Agency for International Development Medicines, Technologies, and Pharmaceutical Services Program- is holding an information session on Managing conflicts of interest in national pharmaceutical systems on 4 October from 14:00-15:30 CET.
Managing conflicts of interest in national pharmaceutical systems (who.int)
Background
The Sustainable Development Goals highlight the importance of good governance for realising development goals, including universal health coverage. Governance concerns include the effective prevention and management of conflicts of interest that may compromise the integrity of decision-making in the public pharmaceutical sector.
Adverse outcomes can occur throughout the pharmaceutical system, including poor quality of care and harm to individuals, wastage of valuable health system resources, and a lack of trust in government institutions. Moreover, conflicts of interest in the public pharmaceutical sector are common in high- and low-income countries alike and are often not well understood.
There is limited information on how conflicts of interest are managed in public pharmaceutical decision-making, particularly in low- and middle-income countries (LMICs).
A recent World Health Organization (WHO) 10-country study identified common gaps, including a lack of organised practices for preventing and managing conflicts of interest. This study and lessons learned from the good governance for medicines program have identified the need to improve the understanding of conflicts of interest in public pharmaceutical decision-making and the need for guidance on preventing and managing conflicts of interest. WHO has recently published a how-to guide for public pharmaceutical-sector committees in low- and middle-income countries to address the need for guidance.
With this, the World Health Organization, in collaboration with United States Agency for International Development (USAID) Medicines, Technologies, and Pharmaceutical Services (MTaPS) Program, is inviting participants to attend the Managing Conflicts of Interest in National Pharmaceutical Systems Information session.
This webinar aims to raise awareness of the need for better management of conflict of interest in public pharmaceutical committees and to share information on practical steps to prevent and manage conflicts of interest.
Register here:
https://who.zoom.us/webinar/register/WN_u4IcbvVFRw2Sm-rm8AjOiQ
We look forward to seeing you then,
Deirdre Dimancesco
Department of Health Products Policy and Standards
World Health Organization
"DIMANCESCO, Deirdre" <dimancescod@who.int>